Ann: NYR Signs Strategic Partnership with US Brain Injury Company, page-32

yeh complete idiot hahahah when something is Acute treatment it’s side effect profile is significantly safer than chronic use. For example NSAIDS short term great for pain and relieve inflammation, medium term they cause stomach ulcers, high blood pressure and risk of stroke in high blood pressure patients. NYR drug is short term the safety profile is already de risked that it hasn’t caused any side effects invivo and pre clinical. Meaning humans will have no side effects. Watch and learn my friend. 70-100 million market cap is where it should be trading like its peers and it’s coming

Also coming from the poster “once MSB gets approved it’s going to $20 dollars a 30 billion dollar market cap” Thanks for the genius post